Catherine Alix-Panabières/umontpellier.fr
Mar 15, 2025, 14:53
Catherine Alix-Panabières: Delighted to attend the First International Symposium on ctDNA-RECIST
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn:
“First DAY! 1st International Symposium ctDNA-RECIST! Very well attended! +/- 100 participants!
Delighted to attend the First International Symposium on ctDNA-RECIST (Response Evaluation Criteria in Solid Tumors) – 14-15 March, 2025 in Aarhus, Denmark organized by Karen-Lise Garm Spindler.
Many key points will be discussed:
- Why can ctDNA-RECIST change oncology?
- ctDNA Analysis – What clinicians must know.
- ctDNA data in metastatic cancers – how far are we?
- Defining ctDNA-response criteria
- Trial designs and study examples
- Workshop session – Clinical trial design.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 15, 2025, 14:47
Mar 15, 2025, 14:28
Mar 15, 2025, 13:53
Mar 15, 2025, 13:47
Mar 15, 2025, 13:41
Mar 15, 2025, 13:33
Mar 15, 2025, 13:24